Literature DB >> 23392441

Widespread colonization of the lung by Tropheryma whipplei in HIV infection.

Catherine Lozupone1, Adela Cota-Gomez, Brent E Palmer, Derek J Linderman, Emily S Charlson, Erica Sodergren, Makedonka Mitreva, Sahar Abubucker, John Martin, Guohui Yao, Thomas B Campbell, Sonia C Flores, Gail Ackerman, Jesse Stombaugh, Luke Ursell, James M Beck, Jeffrey L Curtis, Vincent B Young, Susan V Lynch, Laurence Huang, George M Weinstock, Kenneth S Knox, Homer Twigg, Alison Morris, Elodie Ghedin, Frederic D Bushman, Ronald G Collman, Rob Knight, Andrew P Fontenot.   

Abstract

RATIONALE: Lung infections caused by opportunistic or virulent pathogens are a principal cause of morbidity and mortality in HIV infection. It is unknown whether HIV infection leads to changes in basal lung microflora, which may contribute to chronic pulmonary complications that increasingly are being recognized in individuals infected with HIV.
OBJECTIVES: To determine whether the immunodeficiency associated with HIV infection resulted in alteration of the lung microbiota.
METHODS: We used 16S ribosomal RNA targeted pyrosequencing and shotgun metagenomic sequencing to analyze bacterial gene sequences in bronchoalveolar lavage (BAL) and mouths of 82 HIV-positive and 77 HIV-negative subjects.
MEASUREMENTS AND MAIN RESULTS: Sequences representing Tropheryma whipplei, the etiologic agent of Whipple's disease, were significantly more frequent in BAL of HIV-positive compared with HIV-negative individuals. T. whipplei dominated the community (>50% of sequence reads) in 11 HIV-positive subjects, but only 1 HIV-negative individual (13.4 versus 1.3%; P = 0.0018). In 30 HIV-positive individuals sampled longitudinally, antiretroviral therapy resulted in a significantly reduced relative abundance of T. whipplei in the lung. Shotgun metagenomic sequencing was performed on eight BAL samples dominated by T. whipplei 16S ribosomal RNA. Whole genome assembly of pooled reads showed that uncultured lung-derived T. whipplei had similar gene content to two isolates obtained from subjects with Whipple's disease.
CONCLUSIONS: Asymptomatic subjects with HIV infection have unexpected colonization of the lung by T. whipplei, which is reduced by effective antiretroviral therapy and merits further study for a potential pathogenic role in chronic pulmonary complications of HIV infection.

Entities:  

Mesh:

Year:  2013        PMID: 23392441      PMCID: PMC3734615          DOI: 10.1164/rccm.201211-2145OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  42 in total

1.  [Whipple's disease in an AIDS patient with Kaposi's sarcoma. Report of a case].

Authors:  Olivia Bargiacchi; Anna Maria Salerno; Roberta Brondolo; Giovanni Rizzo; Diego Brustia; Pietro Luigi Garavelli
Journal:  Infez Med       Date:  2010-09

2.  Culture of T. whipplei from the stool of a patient with Whipple's disease.

Authors:  Didier Raoult; Florence Fenollar; Marie-Laure Birg
Journal:  N Engl J Med       Date:  2006-10-05       Impact factor: 91.245

3.  Dysregulated peripheral and mucosal Th1/Th2 response in Whipple's disease.

Authors:  Thomas Marth; Nicole Kleen; Andreas Stallmach; Sabine Ring; Sheriff Aziz; Carsten Schmidt; Warren Strober; Martin Zeitz; Thomas Schneider
Journal:  Gastroenterology       Date:  2002-11       Impact factor: 22.682

4.  Minimum information about a marker gene sequence (MIMARKS) and minimum information about any (x) sequence (MIxS) specifications.

Authors:  Pelin Yilmaz; Renzo Kottmann; Dawn Field; Rob Knight; James R Cole; Linda Amaral-Zettler; Jack A Gilbert; Ilene Karsch-Mizrachi; Anjanette Johnston; Guy Cochrane; Robert Vaughan; Christopher Hunter; Joonhong Park; Norman Morrison; Philippe Rocca-Serra; Peter Sterk; Manimozhiyan Arumugam; Mark Bailey; Laura Baumgartner; Bruce W Birren; Martin J Blaser; Vivien Bonazzi; Tim Booth; Peer Bork; Frederic D Bushman; Pier Luigi Buttigieg; Patrick S G Chain; Emily Charlson; Elizabeth K Costello; Heather Huot-Creasy; Peter Dawyndt; Todd DeSantis; Noah Fierer; Jed A Fuhrman; Rachel E Gallery; Dirk Gevers; Richard A Gibbs; Inigo San Gil; Antonio Gonzalez; Jeffrey I Gordon; Robert Guralnick; Wolfgang Hankeln; Sarah Highlander; Philip Hugenholtz; Janet Jansson; Andrew L Kau; Scott T Kelley; Jerry Kennedy; Dan Knights; Omry Koren; Justin Kuczynski; Nikos Kyrpides; Robert Larsen; Christian L Lauber; Teresa Legg; Ruth E Ley; Catherine A Lozupone; Wolfgang Ludwig; Donna Lyons; Eamonn Maguire; Barbara A Methé; Folker Meyer; Brian Muegge; Sara Nakielny; Karen E Nelson; Diana Nemergut; Josh D Neufeld; Lindsay K Newbold; Anna E Oliver; Norman R Pace; Giriprakash Palanisamy; Jörg Peplies; Joseph Petrosino; Lita Proctor; Elmar Pruesse; Christian Quast; Jeroen Raes; Sujeevan Ratnasingham; Jacques Ravel; David A Relman; Susanna Assunta-Sansone; Patrick D Schloss; Lynn Schriml; Rohini Sinha; Michelle I Smith; Erica Sodergren; Aymé Spo; Jesse Stombaugh; James M Tiedje; Doyle V Ward; George M Weinstock; Doug Wendel; Owen White; Andrew Whiteley; Andreas Wilke; Jennifer R Wortman; Tanya Yatsunenko; Frank Oliver Glöckner
Journal:  Nat Biotechnol       Date:  2011-05       Impact factor: 54.908

5.  A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. AIDS Clinical Trials Group 320 Study Team.

Authors:  S M Hammer; K E Squires; M D Hughes; J M Grimes; L M Demeter; J S Currier; J J Eron; J E Feinberg; H H Balfour; L R Deyton; J A Chodakewitz; M A Fischl
Journal:  N Engl J Med       Date:  1997-09-11       Impact factor: 91.245

6.  Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. Study 006 Team.

Authors:  S Staszewski; J Morales-Ramirez; K T Tashima; A Rachlis; D Skiest; J Stanford; R Stryker; P Johnson; D F Labriola; D Farina; D J Manion; N M Ruiz
Journal:  N Engl J Med       Date:  1999-12-16       Impact factor: 91.245

Review 7.  Whipple disease revealed by lung involvement: a case report and literature review.

Authors:  Geoffrey Urbanski; Philippe Rivereau; Laure Artru; Florence Fenollar; Didier Raoult; Xavier Puéchal
Journal:  Chest       Date:  2012-06       Impact factor: 9.410

8.  Whipple disease of the central nervous system: an unusual occurrence in association with acquired immune deficiency syndrome.

Authors:  Bharat Guthikonda; Emilie Rouah; Bhuvanaswari Krishnan; Suzanne Z Powell; J Clay Goodman; Shankar P Gopinath; Richard K Simpson
Journal:  J Neurosurg       Date:  2010-05       Impact factor: 5.115

9.  Genotyping reveals a wide heterogeneity of Tropheryma whipplei.

Authors:  Wenjun Li; Florence Fenollar; Jean-Marc Rolain; Pierre-Edouard Fournier; Gerhard E Feurle; Christian Müller; Verena Moos; Thomas Marth; Martin Altwegg; Romana C Calligaris-Maibach; Thomas Schneider; Federico Biagi; Bernard La Scola; Didier Raoult
Journal:  Microbiology       Date:  2008-02       Impact factor: 2.777

10.  Persistent reduction of complement receptor 3 alpha-chain expressing mononuclear blood cells and transient inhibitory serum factors in Whipple's disease.

Authors:  T Marth; M Roux; A von Herbay; S C Meuer; G E Feurle
Journal:  Clin Immunol Immunopathol       Date:  1994-08
View more
  87 in total

Review 1.  Homeostasis and its disruption in the lung microbiome.

Authors:  Robert P Dickson; John R Erb-Downward; Gary B Huffnagle
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2015-10-02       Impact factor: 5.464

Review 2.  The Microbiome and the Respiratory Tract.

Authors:  Robert P Dickson; John R Erb-Downward; Fernando J Martinez; Gary B Huffnagle
Journal:  Annu Rev Physiol       Date:  2015-11-02       Impact factor: 19.318

Review 3.  The Lung Microbiome and Its Role in Pneumonia.

Authors:  Benjamin G Wu; Leopoldo N Segal
Journal:  Clin Chest Med       Date:  2018-12       Impact factor: 2.878

Review 4.  The role of the microbiome in exacerbations of chronic lung diseases.

Authors:  Robert P Dickson; Fernando J Martinez; Gary B Huffnagle
Journal:  Lancet       Date:  2014-08-23       Impact factor: 79.321

5.  Exact variance component tests for longitudinal microbiome studies.

Authors:  Jing Zhai; Kenneth Knox; Homer L Twigg; Hua Zhou; Jin J Zhou
Journal:  Genet Epidemiol       Date:  2019-01-08       Impact factor: 2.135

6.  Rationale and Design of the Genomic Research in Alpha-1 Antitrypsin Deficiency and Sarcoidosis Study. Alpha-1 Protocol.

Authors:  Charlie Strange; Robert M Senior; Frank Sciurba; Scott O'Neal; Alison Morris; Stephen R Wisniewski; Russell Bowler; Harry S Hochheiser; Michael J Becich; Yingze Zhang; Joseph K Leader; Barbara A Methé; Naftali Kaminski; Robert A Sandhaus
Journal:  Ann Am Thorac Soc       Date:  2015-10

7.  Incidence of chronic obstructive pulmonary disease in people with HIV in Ontario, 1996-2015: a retrospective population-based cohort study.

Authors:  Tony Antoniou; Zhan Yao; Janet Raboud; Andrea S Gershon
Journal:  CMAJ Open       Date:  2020-02-18

8.  Lung microbiomes: new frontiers?

Authors:  Kathryn DeRiemer; George Thompson
Journal:  Am J Respir Crit Care Med       Date:  2015-04-15       Impact factor: 21.405

Review 9.  Heart-lung interaction via infection.

Authors:  Alison Morris
Journal:  Ann Am Thorac Soc       Date:  2014-01

10.  Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype.

Authors:  Leopoldo N Segal; Jose C Clemente; Jun-Chieh J Tsay; Sergei B Koralov; Brian C Keller; Benjamin G Wu; Yonghua Li; Nan Shen; Elodie Ghedin; Alison Morris; Phillip Diaz; Laurence Huang; William R Wikoff; Carles Ubeda; Alejandro Artacho; William N Rom; Daniel H Sterman; Ronald G Collman; Martin J Blaser; Michael D Weiden
Journal:  Nat Microbiol       Date:  2016-04-04       Impact factor: 17.745

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.